Literature DB >> 21986457

Amelioration of albuminuria in ROCK1 knockout mice with streptozotocin-induced diabetic kidney disease.

Li Zhou1, Fei Liu, Xiao R Huang, Fang Liu, Haiyong Chen, Arther C K Chung, Jianjian Shi, Lei Wei, Hui Y Lan, Ping Fu.   

Abstract

BACKGROUND: Although blockade of Rho kinase with pharmacologic inhibitors ameliorates renal fibrosis and diabetic kidney disease (DKD), the underlined mechanisms remain largely unclear. The present study tested the hypothesis that ROCK1 may regulate the early development of albuminuria via the megalin/cubilin-dependent mechanism.
METHODS: A DKD model was induced in ROCK1 knockout and wild-type mice by streptozotocin (STZ). The effect of deleted ROCK1 on urinary albumin excretion and the expression of megalin/cubilin were examined. In addition, the effect of blocking ROCK activities with an inhibitor (Y-27632) on tubular albumin reabsorption was tested in a normal rat tubular epithelial cell line (NRK52E) under high-glucose conditions. Expression of transforming growth factor (TGF)-β1, interleukin-1β and collagen-1 was also been examined.
RESULTS: Urinary albumin excretion was significantly increased in ROCK1 WT mice at 8 weeks after STZ injection. In contrast, mice lacking ROCK1 gene were protected against the development of albuminuria. This was associated with the protection against the loss of megalin/cubilin and an increase in TGF-β(1), IL-1β, and fibrosis in the kidney. In vitro, we also found that blockade of Rho kinase with inhibitor Y-27632 prevented high-glucose-induced loss of megalin expression and an increase of TGF-β(1), thereby increasing the absorption rate of FITC-labeled albumin by tubular epithelial cells.
CONCLUSION: ROCK1 may play a role in the development of albuminuria in DKD by downregulating the endocytosis receptors complex - megalin/cubilin.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21986457      PMCID: PMC3691875          DOI: 10.1159/000332040

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  42 in total

1.  Transforming growth factor-beta1 reduces megalin- and cubilin-mediated endocytosis of albumin in proximal-tubule-derived opossum kidney cells.

Authors:  Michael Gekle; Petra Knaus; Rikke Nielsen; Sigrid Mildenberger; Ruth Freudinger; Verena Wohlfarth; Christoph Sauvant; Erik I Christensen
Journal:  J Physiol       Date:  2003-10-15       Impact factor: 5.182

Review 2.  Rocks: multifunctional kinases in cell behaviour.

Authors:  Kirsi Riento; Anne J Ridley
Journal:  Nat Rev Mol Cell Biol       Date:  2003-06       Impact factor: 94.444

Review 3.  Rho-kinase: important new therapeutic target in cardiovascular diseases.

Authors:  Kimio Satoh; Yoshihiro Fukumoto; Hiroaki Shimokawa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-27       Impact factor: 4.733

4.  Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo.

Authors:  Sydney Tang; Joseph C K Leung; Katsushige Abe; Kwok Wah Chan; Loretta Y Y Chan; Tak Mao Chan; Kar Neng Lai
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

Review 5.  Rho-kinase in development and heart failure: insights from genetic models.

Authors:  Jianjian Shi; Lumin Zhang; Lei Wei
Journal:  Pediatr Cardiol       Date:  2011-02-16       Impact factor: 1.655

6.  A molecular signature of proteinuria in glomerulonephritis.

Authors:  Heather N Reich; David Tritchler; Daniel C Cattran; Andrew M Herzenberg; Felix Eichinger; Anissa Boucherot; Anna Henger; Celine C Berthier; Viji Nair; Clemens D Cohen; James W Scholey; Matthias Kretzler
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

7.  Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats.

Authors:  Takeshi Kanda; Shu Wakino; Koichi Hayashi; Koichiro Homma; Yuri Ozawa; Takao Saruta
Journal:  Kidney Int       Date:  2003-12       Impact factor: 10.612

8.  Activation of p53 promotes renal injury in acute aristolochic acid nephropathy.

Authors:  Li Zhou; Ping Fu; Xiao R Huang; Fei Liu; Kar Neng Lai; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2009-11-05       Impact factor: 10.121

9.  Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model.

Authors:  Hui Y Lan; Wei Mu; Naruya Tomita; Xiao R Huang; Jin H Li; Hong-Jian Zhu; Ryuichi Morishita; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

10.  Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition.

Authors:  Andras Masszi; Caterina Di Ciano; Gábor Sirokmány; William T Arthur; Ori D Rotstein; Jiaxu Wang; Christopher A G McCulloch; László Rosivall; István Mucsi; András Kapus
Journal:  Am J Physiol Renal Physiol       Date:  2002-12-27
View more
  21 in total

Review 1.  Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.

Authors:  Jianjian Shi; Lei Wei
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

2.  Renal tubular ACE-mediated tubular injury is the major contributor to microalbuminuria in early diabetic nephropathy.

Authors:  Masahiro Eriguchi; Mercury Lin; Michifumi Yamashita; Tuantuan V Zhao; Zakir Khan; Ellen A Bernstein; Susan B Gurley; Romer A Gonzalez-Villalobos; Kenneth E Bernstein; Jorge F Giani
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-29

Review 3.  Rho kinase inhibition in diabetic kidney disease.

Authors:  Radko Komers
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

4.  Cubilin maintains blood levels of HDL and albumin.

Authors:  Obaidullah Aseem; Brian T Smith; Marion A Cooley; Brent A Wilkerson; Kelley M Argraves; Alan T Remaley; W Scott Argraves
Journal:  J Am Soc Nephrol       Date:  2013-12-19       Impact factor: 10.121

5.  High glucose reduces megalin-mediated albumin endocytosis in renal proximal tubule cells through protein kinase B O-GlcNAcylation.

Authors:  Diogo de Barros Peruchetti; Rodrigo Pacheco Silva-Aguiar; Gabriela Marques Siqueira; Wagner Barbosa Dias; Celso Caruso-Neves
Journal:  J Biol Chem       Date:  2018-06-05       Impact factor: 5.157

6.  CKD Stimulates Muscle Protein Loss Via Rho-associated Protein Kinase 1 Activation.

Authors:  Hui Peng; Jin Cao; Rizhen Yu; Farhad Danesh; Yanlin Wang; William E Mitch; Jing Xu; Zhaoyong Hu
Journal:  J Am Soc Nephrol       Date:  2015-06-08       Impact factor: 10.121

Review 7.  Rho/ROCK signaling in motility and metastasis of gastric cancer.

Authors:  Tasuku Matsuoka; Masakazu Yashiro
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

8.  TMBIM6 promotes diabetic tubular epithelial cell survival and albumin endocytosis by inhibiting the endoplasmic reticulum stress sensor, IRE1α.

Authors:  Huidi Xie; Yang Shi; Ying Zhou; Hongfang Liu
Journal:  Mol Biol Rep       Date:  2022-07-20       Impact factor: 2.742

Review 9.  Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions.

Authors:  Linda Julian; Michael F Olson
Journal:  Small GTPases       Date:  2014-07-10

Review 10.  Rho Kinases and Cardiac Remodeling.

Authors:  Toru Shimizu; James K Liao
Journal:  Circ J       Date:  2016-06-01       Impact factor: 2.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.